GB Sciences IncOver The Counter Market:GBLX
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0001 / 0.0001
- Day Range
- 52 Week Range
- Volume38,490
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GBLX |
|---|---|---|
| 09:44 ET | 2500 | 0.0001 |
| 11:02 ET | 15000 | 0.0001 |
| 11:03 ET | 15100 | 0.0001 |
| 11:23 ET | 4000 | 0.0001 |
| 02:16 ET | 1890 | 0.0001 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
GB Sciences Inc | 40.7K | 0.0x | --- |
Regenicin Inc | 15.4K | 0.0x | --- |
Vioquest Pharmaceuticals Inc | 43.1K | 0.0x | --- |
Immunotech Laboratories Inc | 57.5K | 0.0x | --- |
Vaxxinity Inc | 25.4K | 0.0x | --- |
Life Stem Genetics Inc | 24.6K | 0.0x | --- |
Company Information
GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company. It creates patented, disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. (GBSGB). The primary focus for the development of its lead program has been in evaluating suitable development partners that will assist it in preparing its cannabinoid-based formulas for the treatment of the motor symptoms of Parkinson's disease in human clinical trials. It is engaged in the research and development of plant-inspired medicines, with virtual operations in North America and Europe. GBSGB’s has a portfolio of intellectual property containing both proprietary plant-inspired formulations and its artificial intelligence-enabled drug discovery platform, and critical research contracts and key supplier arrangements. Its intellectual property covers a range of 65 medical conditions.
Contact Information
- Headquarters
- 6450 Cameron St Ste 110ALAS VEGAS, NV, United States 89118-4337
- Phone
- 888-895-3594
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer, Chief Financial Officer, Chief Scientific Officer
- Andrea Small-Howard
- Chief Financial Officer, Treasurer
- Zach Swarts
- Company Secretary
- Gary Henrie
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $40.7K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 407.1M |
GB Sciences Inc does not pay a dividend. | |
Beta | 0.54 |
EPS | $0.00 |
Book Value | $-0.01 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
